which glp-1 is better for weight loss comparison… but make it evidence-based 📊 Because what works best? Depends on the patient—not the trend. #GLP1 #WeightLoss #HealthcareProvider #Semaglutide The GLP-1 Access Gap: Mapping

GLP-1s (short for glucagon-like peptide-1 receptor agonists) are a group of medications first approved by the FDA in 2005 to help regulate blood sugar in people with Type 2 diabetes

But like many multitasking meds, it's not all sunshine

Moving from retatrutide to a moderate dose of semaglutide or tirzepatide can provide ongoing appetite suppression at a lower cost point

While the length of these effects is unclear (Circana, 2025), these consumption changes are likely to have sweeping consequences for each grocery store, restaurant, food manufacturer, retailer, and farmer in the food system

It is not recommended to microdose Ozempic or Wegovy to save money, because these medications are designed to work at their standard doses

After your initial health assessment, you'll be contacted by an expert clinician